Using an expression quantitative trait loci approach could identify genetic variations affecting growth and obesity in mice, and may have applications in humans.
Caliper Life Sciences launched the Caliper LabChip EZ Reader series for in-house kinase profiling. The series includes the new EZ Reader II system, a bench-top reader to use for real-time kinetic analysis with push-button operation, and the EZ Reader system.
In an effort to fight back against the stifling effect of scientific knowledge being kept under wraps, researchers are creating an open-source community that allows them to advance science by sharing data.
Fluorescent proteins have been available for several years, but new instruments that measure fluorescence have allowed researchers to use such proteins to study gene expression.
The genetic sequencing of many infectious agents has allowed researchers to use DNA microarrays to study disease. Scientists are exploring a number of areas, including host-pathogen interactions and DNA-protein interactions.
Scientists are using a variety of tools and techniques to determine how the H5N1 influenza virus is mutating.
Malaysia is developing centers of excellence and fighting brain drain as it works to establish itself as a biotech hotbed.
The collaborative efforts of multidisciplinary scientists are pushing the boundaries of cancer research.
The Protein Structure Initiative is the largest, most ambitious effort of its kind. Its success depends on imagination and innovation.
The full potential of protein array technology is within reach, but there are still hurdles to be overcome before it is completely realized.
RNA is difficult to isolate from any sample, but is especially difficult when its cellular source is limited. Researchers say newer RNA isolation methods are needed to overcome these challenges.
A new paradigm in biological research is taking shape, and now systems biologists have the money needed to put them on the road to solving key biological problems.
Researchers are working to sort out genetic markers for human diseases using single nucleotide polymorphisms (SNPs).
Finding new protein biomarkers and using them in combinations promises earlier detection of a variety of diseases, from Alzheimer’s to cancer, but identifying these biomarkers depends on negotiating difficult technological challenges.
After some delay, skeptical neuroscientists realize the awesome power of genomic and proteomic tools for solving the mysteries of mental illness.